BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY

被引：0
|
作者：
Lugogo, Njira L.
Cote, Andreanne
Bourdin, Arnaud
Peters, Anju T.
Bacharier, Leonard B.
Xia, Changming
Pandit-Abid, Nami
Jacob-Nara, Juby A.
Sacks, Harry
Rowe, Paul J.
Deniz, Yamo
Soliman, Mena
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.2843
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4721A / 4724A
页数：4
相关论文
共 50 条
  • [21] BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA TREATED WITH DUPILUMAB IN A REALWORLD SETTING: RESULTS FROM THE RAPID REGISTRY
    Lugogo, N. L.
    Soler, X.
    Menzies-Gow, A.
    Peters, A. T.
    Cote, A.
    Hilberg, O.
    Xia, C.
    Rimington, T.
    Zhang, Y.
    Gomez, L. de Prado
    Rowe, P. J.
    Radwan, A.
    Jacob-Nara, J. A.
    Deniz, Y.
    THORAX, 2022, 77 : A79 - A80
  • [22] Multiple sclerosis patients initiating dimethyl fumarate versus fingolimod in the real-world setting have baseline characteristics associated with worse clinical prognosis
    Hersh, C.
    Lei, Y.
    de Moor, C.
    Rudick, R.
    Williams, J. R.
    Kieseier, B.
    Koulinska, I.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 866 - 867
  • [23] DUPILUMAB EFFICACY IN PATIENTS WITH TYPE 2 ASTHMA WITH/WITHOUT ALLERGIC PHENOTYPE RECEIVING HIGH-DOSE INHALED CORTICOSTEROIDS
    Bourdin, A.
    Virchow, J.
    Papi, A.
    Lugogo, N.
    Halpin, D.
    Daizadeh, N.
    Ortiz, B.
    Djandji, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S32 - S33
  • [24] Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufi L.
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S825 - S825
  • [25] The RAPID Registry: A Global Real-World Cohort of Patients Receiving Dupilumab for the Treatment of Moderate-to-Severe Asthma
    Jain, N.
    Soong, W.
    Settipane, R. A.
    Gall, R.
    Zhen, C.
    Zhang, Y.
    Tmirah, H.
    Jacob-Nara, J. A.
    Ortiz, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [26] Baseline characteristics of patients treated with vedolizumab in Taiwan: real-world evidence from TSIBD registry
    Lin, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Chou, Jen-Wei
    Chung, Chen-Shuan
    Shieh, Ming-Jium
    Yen, Hsu-Heng
    Liu, Yuh-Hwa
    Tai, Wei-Chen
    Wu, Deng-Chyang
    Hsu, Wen-Hung
    Lu, Chien-Yu
    Lu, Lung-Sheng
    Tsai, Tzung-Jiun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 304 - 305
  • [27] CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS REACHING A HIGH DAILY DOSE OF IDEGLIRA SIX MONTHS AFTER INITIATION IN A REAL-WORLD SETTING
    Prager, R.
    Price, H.
    Blueher, M.
    Fernandes, J.
    Moller, J. B.
    Schultes, B.
    VALUE IN HEALTH, 2018, 21 : S122 - S122
  • [28] Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    BMJ OPEN RESPIRATORY RESEARCH, 2018, 5 (01):
  • [29] Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting
    Sadetsky, N.
    Corvino, F.
    Surinach, A.
    Goodman, G.
    MELANOMA RESEARCH, 2016, 26 : E42 - E42
  • [30] Baseline characteristics of the first real-world atopic dermatitis patients on Dupilumab in Germany - interim analysis of the PROLEAD study
    Riebel, S.
    Augustin, M.
    Bley, O.
    Schmitt, J.
    Sebastian, M.
    Zaun, S.
    Thaci, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 190 - 190
12345